interleukin-8 and Weight-Gain

Cancer progression is associated with significant cachexia-induced weight loss and stomatitis. Pentoxifylline (PTX) is a drug shown to have beneficial anti-inflammatory effects in cancer patients, mainly through anti-TNFα mechanisms. This study determined the PTX effects and mode of action on weight-loss, stomatitis, and survival in colon cancer patients treated with chemotherapy, examining the kinetics of tumor markers and cytokine levels.. Forty patients with metastatic colon cancer receiving chemotherapy, were randomized in this study. Seventeen patients were assigned to the treatment group - 8 received a full PTX dose (400 mg TID) and 9 a reduced dose (200 mg TID). Results were compared to 23 untreated, control patients. Blood analysis of tumor markers (CEA and TPS), inflammatory cytokines (IL-1β, IL-6, IL-8, TNFα, TNF-R), CRP and sIL-2R, were performed. Additionally, clinical parameters were assessed.. Patients treated with PTX (full/reduced doses), gained significant weight, and experienced a reduction in stomatitis, resulting in multiple beneficial effects, including improved life quality. Significant reductions in CRP, sIL-2R, and inflammatory cytokine levels, correlated to increases in weight and a reduction in stomatitis. A similar pattern was observed in tumor marker levels, where decreasing levels were correlated with weight gain and reduction in inflammatory cytokine levels.. Colon cancer patients receiving PTX with chemotherapy, experienced weight gain and reduced stomatitis occurrence. Beneficial PTX effects were correlated to significant decreases in patient inflammatory cytokines and tumor marker levels, probably due to PTX mode of action.

Topics: Anti-Inflammatory Agents; Biomarkers, Tumor; Carcinoembryonic Antigen; Colonic Neoplasms; Cytokines; Humans; Interleukin-6; Interleukin-8; Kinetics; Pentoxifylline; Stomatitis; Tumor Necrosis Factor-alpha; Weight Gain

Increasing physical activity in pregnancy may improve pregnancy outcomes for obese women. Exercise could reduce gestational weight gain, improve the maternal circulating lipid profile as well as alter leptin, Interleukin-8 (IL-8) and Monocyte Chemoattractant Protein-1 (MCP-1) levels.. The aim of this study was to investigate the effects of exercise on gestational weight gain, maternal circulating lipids, IL-8, MCP-1 and leptin levels in obese pregnant women.. The analysis was performed in the 35 obese women enrolled in the pilot BAMBINO randomised controlled trial who provided blood samples at 12- and 28-weeks gestation. Women in the exercise intervention arm received an individualised exercise plan. Blood samples, exercise diary and pedometer data were obtained at 12-, 20-, 28- and 36-weeks' gestation. Cord blood was obtained at delivery.. Women in the exercise arm exercised more than those in the control arm (P = 0.038). There was no difference in gestational weight gain, excess gestational weight gain, MCP-1 and leptin levels between women in the exercise intervention (n = 19) or the control arm (n = 16). IL-8 was not detectable. Exercise did not alter the maternal lipid profile.. The low level of physical activity achieved in obese women in the exercise intervention arm was insufficient to alter gestational weight gain, MCP-1, leptin or circulating lipid levels.

Topics: Adult; Chemokine CCL2; Exercise; Female; Humans; Interleukin-8; Leptin; Obesity; Pilot Projects; Pregnancy; Pregnancy Complications; Weight Gain; Young Adult

Cystic fibrosis (CF) is characterized by malnutrition, chronic pulmonary inflammation, and oxidative stress. Whey protein is rich in sulfhydryl groups and is recognized for its ability to increase glutathione and reduce oxidative stress. Previously, we have shown that supplementation with whey increased intracellular glutathione levels in patients with CF. We have subsequently shown that hyperbaric pressure treatment of whey protein promotes the release of novel peptides for absorption, increases intracellular glutathione in healthy subjects, and reduces in vitro production of interleukin (IL)-8. We hypothesized that pressurized whey supplementation in children and adults with CF could have significant nutritional and anti-inflammatory benefits. A pilot open-label study of 1-month dietary supplementation with pressurized whey in CF patients was undertaken to assess the effects. Twenty-seven patients with CF (nine children, 18 adults) were enrolled. The dose of pressurized whey was 20 g/day in patients less than 18 years of age and 40 g/day in older patients. Anthropometric measures, pulmonary function, serum C-reactive protein (CRP), whole blood glutathione, and whole blood IL-8 and IL-6 responses to phytohemagglutinin (PHA) stimulation were measured at baseline and at 1 month. Three adults withdrew (one with gastrointestinal side effects, two with acute infection). Both children and adults showed enhancements in nutritional status, as assessed by body mass index. Children showed improvement in lung function (forced expiratory volume in 1 second). The majority of patients with an initially elevated CRP showed a decrease. PHA-stimulated IL-8 responses tended to decrease in the adults. Whole blood glutathione levels did not change. Thus, oral supplementation with pressurized whey improves nutritional status and can have additional beneficial effects on inflammation in patients with CF.

Topics: Adolescent; Adult; Anti-Inflammatory Agents; Body Mass Index; C-Reactive Protein; Child; Cystic Fibrosis; Dietary Proteins; Dietary Supplements; Female; Forced Expiratory Volume; Glutathione; Humans; Interleukin-8; Lung; Male; Milk Proteins; Nutritional Status; Oxidative Stress; Pilot Projects; Pressure; Weight Gain; Whey Proteins; Young Adult

During the first week posthatch, the avian immune system is immature and inefficient at protecting chicks from invading pathogens. Among immunomodulators, beta-glucans are known as biological response modifiers due to their ability to activate the immune system. Current research suggests that beta-glucans may enhance avian immunity; however, very little is known about their influence on regulation of immune function. A study was performed to evaluate the effects of dietary beta-glucan on growth performance, immune organ weights, peripheral blood cell profiles, and immune-related gene expression in the intestine. One-day-old chicks were fed a diet containing 0, 0.02, or 0.1% yeast beta-glucan (n = 30/treatment). On d 7 and 14 posthatch, body and relative immune organ weights were measured and small intestinal sections were collected to evaluate gene expression by quantitative real-time PCR. Peripheral blood samples were also collected to determine heterophil:lymphocyte ratios. Supplementation of beta-glucan did not significantly affect BW gains, and no significant differences were observed among groups for relative immune organ weights or heterophil:lymphocyte ratios. Compared with controls, expression of interleukin (IL)-8 was downregulated in the beta-glucan-treated groups on d 7 and 14. On d 14, beta-glucan inclusion resulted in increased inducible nitric oxide synthase expression. Expression of IL-18 was upregulated on d 7 but reduced on d 14 due to beta-glucan supplementation. On d 7, interferon-gamma and IL-4 expression decreased in the beta-glucan-treated groups. However, on d 14, IL-4 expression was upregulated in the supplemented groups. Intestinal expression of IL-13 was also downregulated in the beta-glucan-treated birds on d 7. These results suggest that dietary inclusion of beta-glucans altered the cytokine-chemokine balance; however, it did not elicit a robust immune response in the absence of a challenge, resulting in no deleterious effects on performance.

Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; beta-Glucans; Blood Cell Count; Chickens; Diet; Gene Expression Regulation; Interleukin-8; Intestinal Mucosa; Intestines; Weight Gain

We describe testicular changes in Wistar and Sprague-Dawley rats following oral administration of DF2156A, a novel allosteric inhibitor of the CXCR1/CXCR2 receptors of interleukin-8. These testicular changes, which were associated with clinical signs, modifications of body weight parameters (decrease of body weight and weight gain) and a decrease of testosterone serum levels, were not considered to be a direct toxic effect of the test substance but secondary to a likely induced stress resulting from the oral administration of a high dose (200 mg/kg/day) of the test substance to male rats for a period of six weeks. Testicular changes consisted of seminiferous tubules atrophy and germinal cell degeneration and only occurred in animals presenting clinical signs of transient visible weight loss, ruffled fur and/or weakened condition, and/or decreased body weight and weight gain. A decrease in serum testosterone levels was only observed in those Sprague-Dawley rats affected by decreased body weight, weight gain and testicular changes. Only a single Wistar rat with testicular changes exhibited relevant reduced levels of circulating testosterone. Sperm analysis in terms of motility, morphology and number of sperm cells was altered in males presenting with morphological changes in the testes. Sprague-Dawley rats with testicular changes were more numerous and with more pronounced lesions than were Wistar rats.

Topics: Administration, Oral; Animals; Body Weight; Interleukin-8; Male; Organ Size; Rats; Rats, Sprague-Dawley; Rats, Wistar; Semen; Sperm Motility; Testis; Testosterone; Weight Gain

Chemotherapy-induced gastrointestinal (GI) toxicity is a common adverse effect of cancer treatment. We used preweaned piglets as models to test our hypothesis that the immunomodulatory and GI trophic effects of bovine colostrum would reduce the severity of GI complications associated with doxorubicin (DOX) treatment. Five-day-old pigs were administered DOX (1 × 100 mg/m(2)) or an equivalent volume of saline (SAL) and either fed formula (DOX-Form, n = 9, or SAL-Form, n = 7) or bovine colostrum (DOX-Colos, n = 9, or SAL-Colos, n = 7). Pigs were euthanized 5 days after initiation of chemotherapy to assess markers of small intestinal function and inflammation. All DOX-treated animals developed diarrhea, growth deficits, and leukopenia. However, the intestines of DOX-Colos pigs had lower intestinal permeability, longer intestinal villi with higher activities of brush border enzymes, and lower tissue IL-8 levels compared with DOX-Form (all P < 0.05). DOX-Form pigs, but not DOX-Colos pigs, had significantly higher plasma C-reactive protein, compared with SAL-Form. Plasma citrulline was not affected by DOX treatment or diet. Thus a single dose of DOX induces intestinal toxicity in preweaned pigs and may lead to a systemic inflammatory response. The toxicity is affected by type of enteral nutrition with more pronounced GI toxicity when formula is fed compared with bovine colostrum. The results indicate that bovine colostrum may be a beneficial supplementary diet for children subjected to chemotherapy and subsequent intestinal toxicity.

Topics: Animals; Animals, Newborn; Antibiotics, Antineoplastic; C-Reactive Protein; Cattle; Colostrum; Disease Models, Animal; Doxorubicin; Enteral Nutrition; Female; Humans; Infant Formula; Infant, Newborn; Inflammation Mediators; Interleukin-8; Intestinal Mucosa; Intestine, Small; Male; Microvilli; Mucositis; Nutritional Status; Permeability; Sus scrofa; Weight Gain

Weight gain before the clinical diagnosis of necrotising enterocolitis (NEC) is described as a predictive factor.. Weight gain of more than 5% one day prior to clinical suspicion plus increase of plasma Iinterleukin-8 (IL-8) are predictive for NEC.. 48 infants with diagnosis of NEC stage II and III were enrolled in a case-control study. Oral and parenteral nutrition, diuresis and kinetics of weight and of IL-8 were documented.. 31 infants with NEC-II and 17 infants with NEC-III were enrolled. Weight gain>5% occurred in 35.3% of NEC-III, in 0% of NEC-II and in 4.2% of the control group. IL-8 increased significantly [NEC-III (6 561.4 pg/mL) vs. NEC-II: (326.7 pg/mL) vs. control group (38.9 pg/mL); p<0.05]. Sensitivity of IL-8 in NEC-II was 87.10% (70.15-96.25) and in NEC-III 100.00% (80.33-100.00). Sensitivity of weight gain was 0.00% (0.00-11.32) in NEC-II and 35.29% (14.30-61.65) in NEC-III.. Weight gain>5% was found in only 35.3% of the cases with NEC-III. Combination of weight gain and IL-8 did not improve the diagnosis of NEC.

Topics: Biomarkers; Enterocolitis, Necrotizing; Female; Humans; Infant, Newborn; Infant, Premature; Interleukin-8; Male; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Weight Gain

Weaned calves (n = 98; 256 ± 11.5 kg) were used to evaluate the impact of improving trace mineral (TM) status using a multielement TM injection 28 d before transit on markers of inflammatory and stress responses in response to transit and postshipping growth performance. On d 0 of a 28-d preconditioning program, calves received subcutaneous TM injection (MM; n = 48) containing 15, 10, 5, and 60 mg/mL of Cu, Mn, Se, and Zn, respectively, or physiological saline injection (SAL; n = 48). On d 28, steers were weighed, half of the steers from each treatment were transported for a 20-h transit stress period (SHIP; n = 24 per injection treatment), and half of the steers were returned to their pens for 20 h of feed and water restriction without transit (NOSHIP; n = 24 per injection treatment). The SHIP steers were unloaded on d 29 and all steers (SHIP and NOSHIP) were immediately weighed and sorted into new pens (n = 4 steers per pen) for the growing period. At the start of finishing (d 113), steers received a second MM or SAL, resulting in a 2 × 2 × 2 factorial (n = 12 steers per treatment combination). Samples of blood were collected on d 28, 29, and 34 and liver on d 22 and 40. The initial MM increased liver Cu, Se, and Zn concentrations of cattle (P ≤ 0.02) but did not affect ADG during preconditioning (P = 0.89) or BW shrink as a result of transit (P ≥ 0.52). Plasma Fe concentrations were decreased after the transit stress period in SHIP calves (P ≤ 0.05) relative to NOSHIP calves but recovered 5 d after transit, and serum IL-8 concentrations were greater in SAL-SHIP steers than MM-SHIP steers (P = 0.04). Altering TM status through MM caused steers to have lesser ADG (P = 0.03) during the 14-d period after transit (d 29 through 43) but did not affect growth during the growing period (d 5 through 112; P ≥ 0.40). Minimal effects on finishing performance and carcass characteristics were noted, but there was a 3-way interaction (P ≤ 0.02) in which SAL-NOSHIP-MM steers had the greatest yield grade (YG) and smallest ribeye area (REA) and SAL-SHIP-MM steers had the least YG and largest REA. Overall, a MM 28 d before transit or before feed and water restriction did not affect the inflammatory response or plasma TM concentrations but decreased ADG in the 14-d period after transit. Trace mineral injection had limited effects on overall growth performance and carcass characteristics, likely because steer initial TM status was well within the adequate range.

Topics: Animals; Blood Cell Count; Body Composition; Cattle; Copper; Inflammation; Injections, Subcutaneous; Interleukin-8; Male; Random Allocation; Selenium; Stress, Psychological; Time Factors; Trace Elements; Transportation; Weight Gain; Zinc

Eight chicken cytokine genes (IL-1beta, IL-2, IL-8, IL-15, IFN-alpha, IFN-gamma, TGF-beta4, lymphotactin) were evaluated for their adjuvant effect on a suboptimal dose of an Eimeria DNA vaccine carrying the 3-1E parasite gene (pcDNA3-1E). Chickens were given two subcutaneous injections with 50 microg of the pcDNA3-1E vaccine plus a cytokine expression plasmid 2 weeks apart and challenged with Eimeria acervulina 1 week later. IFN-alpha (1 microg) or 10 microg of lymphotactin expressing plasmids, when given simultaneously with the pcDNA3-1E vaccine, significantly protected against body weight loss induced by E. acervulina. Parasite replication was significantly reduced in chickens given the pcDNA3-1E vaccine along with 10 microg of the IL-8, lymphotactin, IFN-gamma, IL-15, TGF-beta4, or IL-1beta plasmids compared with chickens given the pcDNA3-1E vaccine alone. Flow cytometric analysis of duodenum intraepithelial lymphocytes showed chickens that received the pcDNA3-1E vaccine simultaneously with the IL-8 or IL-15 genes had significantly increased CD3+ cells compared with vaccination using pcDNA3-1E alone or in combination with the other cytokine genes tested. These results indicate that the type and the dose of cytokine genes injected into chickens influence the quality of the local immune response to DNA vaccination against coccidiosis.

Topics: Adjuvants, Immunologic; Animals; Chickens; Coccidiosis; Drug Evaluation, Preclinical; Duodenum; Eimeria; Genetic Vectors; Interferon-alpha; Interferon-gamma; Interferons; Interleukin-1; Interleukin-15; Interleukin-2; Interleukin-8; Interleukins; Lymphokines; Parasite Egg Count; Poultry Diseases; Sialoglycoproteins; Specific Pathogen-Free Organisms; Transforming Growth Factor beta; Vaccination; Vaccines, DNA; Weight Gain